Letter to the Editor: MicroRNA levels and anti-VEGF therapy in glioblastoma

J Neurosurg. 2016 Oct;125(4):1050-1051. doi: 10.3171/2016.3.JNS16523. Epub 2016 Jun 10.

Authors

Rafael Roesler^{1

2}, Gustavo R Isolan^{1

2}

Affiliations

¹ Institute for Basic Health Sciences, Cancer and Neurobiology Laboratory, Experimental Research Center, Clinical Hospital (CPE-HCPA), Federal University of Rio Grande do Sul, Porto Alegre, Brazil; and.
² Clinical Hospital (CPE-HCPA), Federal University of Rio Grande do Sul, Advanced Center of Neurology and Neurosurgery (CEANNE)-Brazil, Porto Alegre, Brazil.

PMID: 27285543
DOI: 10.3171/2016.3.JNS16523

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Bevacizumab
Brain Neoplasms
Glioblastoma*
Humans
MicroRNAs
Vascular Endothelial Growth Factor A*

Substances

MicroRNAs
Vascular Endothelial Growth Factor A
Bevacizumab